Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Daiichi Sankyo
Daiichi Sankyo
Daiichi sues Seattle Genetics over tech used in high-profile ADC
Fierce Biotech
Tue, 11/5/19 - 10:34 am
Daiichi Sankyo
Seattle Genetics
antibody-drug conjugate
AstraZeneca
DS-8201
Daiichi Sankyo pulls out of U.S. pain market amid oncology pivot, opioid scrutiny
Fierce Pharma
Mon, 11/4/19 - 07:27 pm
Daiichi Sankyo
oncology
painkillers
opioids
opioid crisis
Daiichi Sankyo initiates clinical trial of DS-7300 in collaboration with Sarah Cannon Research Institute
Pharmaceutical Business Review
Fri, 11/1/19 - 10:35 am
Daiichi Sankyo
Sarah Cannon Research Institute
antibody-drug conjugate
DS-7300
clinical trials
solid tumors
Recent Job Cuts in the Biopharma Industry
BioSpace
Mon, 10/7/19 - 11:29 pm
Tocagen
Sanofi
Amneal
Daiichi Sankyo
Integra Life Sciences
Aclaris
Bayer
Novartis
Illumina
Merck
Roche Molecular Systems
Prometheus Labs
layoffs
Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata
Pharmaforum
Sun, 09/22/19 - 11:02 pm
Astellas
AML
Xospata
Europe
Daiichi Sankyo
Astellas' AML drug wins over CHMP — strengthening lead on Daiichi Sankyo
Endpoints
Fri, 09/20/19 - 10:40 pm
Astellas
FDA
gilteritinib
Europe
AML
Daiichi Sankyo
Daiichi Sankyo to cut 69 opioid sales jobs
Beckers Hospital Review
Tue, 08/13/19 - 10:26 am
Daiichi Sankyo
opioids
layoffs
drug reps
Daiichi Sankyo scores landmark FDA OK for rare tumor drug — albeit with restrictions
Endpoints
Mon, 08/5/19 - 11:32 am
Daiichi Sankyo
FDA
pexidartinib
Turalio
tenosynovial giant cell tumors
FDA declines to approve Daiichi Sankyo's blood cancer treatment
Reuters
Fri, 06/21/19 - 11:55 pm
Daiichi Sankyo
FDA
quizartinib
acute myeloid leukemia
5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
Motley Fool
Wed, 06/12/19 - 09:45 am
Vertex Pharmaceuticals
VX-445
tezacaftor/ivacaftor
AbbVie
upadacatinib
Daiichi Sankyo
trastuzumab deruxtecan
Celgene
liso-cel
Novartis
LY3298176
Daiichi Sankyo Denies Report That It's Selling Over-the-Counter Drug Unit
BioSpace
Fri, 05/24/19 - 10:40 am
Daiichi Sankyo
OTC
Daiichi Sankyo in talks over OTC unit sale – reports
Pharmaforum
Thu, 05/23/19 - 09:56 am
Daiichi Sankyo
M&A
OTC
Daiichi Sankyo comes up way short of promised avian flu vaccine production
Fierce Pharma
Wed, 05/22/19 - 08:34 pm
Daiichi Sankyo
vaccines
Japan
avian flu
drug shortages
Daiichi Sankyo Takes Two Products to FDA Advisory Panel; Gets One Yes, One No
BioSpace
Wed, 05/15/19 - 11:42 am
Daiichi Sankyo
FDA
quizartinib
acute myeloid leukemia
pexidartinib
TGCT
FDA questions credibility of Daiichi data ahead of AdComm
Fierce Biotech
Mon, 05/13/19 - 09:32 am
FDA
Daiichi Sankyo
quizartinib
acute myeloid leukemia
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs
Yahoo/Benzinga
Sat, 05/11/19 - 12:31 pm
biotech
Achillion
Sesen Bio
The Medicines Company
Amgen
Daiichi Sankyo
earnings
AstraZeneca's share dilution gamble on Daiichi drug pays off
Biopharma Dive
Thu, 05/9/19 - 10:49 am
AstraZeneca
Daiichi Sankyo
trastuzumab deruxtecan
metastatic breast cancer
AZ and Daiichi to file new breast cancer drug after trial success
Pharmaforum
Wed, 05/8/19 - 10:05 am
AstraZeneca
Daiichi Sankyo
trastuzumab deruxtecan
antibody-drug conjugate
Daiichi picks immuno-oncology bispecific, triggering payout to Zymeworks
Fierce Biotech
Thu, 04/25/19 - 11:45 am
Daiichi Sankyo
immuno-oncology
Zymeworks
bispecific antibodies
AstraZeneca pays up to $6.9 billion in Daiichi Sankyo cancer deal
Yahoo/Reuters
Fri, 03/29/19 - 10:06 am
AstraZeneca
Daiichi Sankyo
breast cancer
trastuzumab deruxtecan
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »